Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Analytical Science

Discovery & Development Small Molecules

Planning for Production Scale

| Daniel Maier

The development of an industrial process should begin right at the start – the preclinical stage.

Discovery & Development Analytical Science

Source of Light – and Inspiration

| Rich Whitworth

A new center for electron bio-imaging was officially opened by one of the three Nobel Prize winners.

Manufacture Analytical Science

Faster for Pharma

| Joanna Cummings

Sitting Down With... Melissa Hanna-Brown, Analytical Technology & Innovation Lead, Pfizer Global R&D, Sandwich, UK.

Manufacture Quality & Compliance

Cutting-Edge LC-MS: Essential Technology in the Pharma Toolbox

| Brunhilde Guessregen

Where would drug development be without liquid chromatography-mass spectrometry – the hyphenated technique more commonly known as LC-MS?

Manufacture Analytical Science

The Future’s RoSA

| Joanna Cummings

A robotic arm takes mass spec analysis of 3D objects to the next level.

Discovery & Development Analytical Science

Pure and Simple(r)

| Stephanie Sutton

Making cancer drugs cheaper and more effective – with a paper “coffee” filter.

Discovery & Development Bioprocessing - Upstream & Downstream

Boosting mAb Manufacture

| David Westman

mAbs are an important growth area for the biopharma industry – so we need more effective purification technologies.

Discovery & Development Analytical Science

Putting Peptides on the Map

Streamlined workflows help scientists plot a course for painless peptide mapping

Discovery & Development Biosimilars

What Regulators Want

| Bruno Speder

The path to market for a biosimilar involves an abbreviated approval process, focused on proving “biosimilarity”.

Discovery & Development Biosimilars

I’m a (Biosimilars) Believer!

| Stephanie Sutton

Why does the full potential of biosimilars remain untapped? Four experts weigh in.

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register